earnings
NS
AMEX · NSRX
Nasus Pharma Ltd.
Healthcare · Biotechnology
$3.35
Down-$0.20 (-5.63%)
Updated Sep 11, 2026, 10:56 AM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 58.89M
- P/E ratio
- -38.44
- Dividend yield
- 0.00%
- 52-week range
- $1.98 – $5.20
- Volume
- 10.72K
- Avg. volume
- 13.21K
Price performance
NSRX price history
1M range · 20 trading sessions · Daily adjusted prices
NSRX closed at $3.35 after 20 trading sessions, up 4.69% for the selected period.
- Last close
- $3.35
- Period change
- +4.69%
- Period low
- $3.20
- Period high
- $4.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $3.16 | $3.4769 | $3.16 | $3.35 | 10.72K |
| Sep 9, 2026 | $3.47 | $3.565 | $3.17 | $3.55 | 4.44K |
| Sep 8, 2026 | $3.53 | $3.9731 | $3.47 | $3.88 | 8.68K |
| Sep 4, 2026 | $3.5296 | $3.735 | $3.5296 | $3.735 | 829.62 |
| Sep 3, 2026 | $3.515 | $3.765 | $3.23 | $3.75 | 15.1K |
| Sep 2, 2026 | $4.0368 | $4.0368 | $3.68 | $3.77 | 1.89K |
| Sep 1, 2026 | $3.85 | $4.08 | $3.43 | $3.825 | 15.68K |
| Aug 31, 2026 | $3.9017 | $4.10 | $3.87 | $4.084 | 4.66K |
| Aug 28, 2026 | $3.985 | $4.10 | $3.9838 | $4.10 | 14.57K |
| Aug 27, 2026 | $4.05 | $4.10 | $4.05 | $4.10 | 8.83K |
| Aug 26, 2026 | $4.09 | $4.09 | $3.8688 | $4.05 | 4.46K |
| Aug 25, 2026 | $4.08 | $4.10 | $3.99 | $4.10 | 10.21K |
| Aug 24, 2026 | $3.98 | $4.07 | $3.765 | $4.07 | 17.39K |
| Aug 21, 2026 | $3.805 | $4.00 | $3.655 | $4.00 | 29.9K |
| Aug 20, 2026 | $3.665 | $3.85 | $3.51 | $3.85 | 11.25K |
| Aug 19, 2026 | $3.15 | $3.86 | $3.15 | $3.84 | 39.07K |
| Aug 18, 2026 | $3.65 | $3.75 | $3.3681 | $3.65 | 18.69K |
| Aug 17, 2026 | $3.70 | $3.70 | $3.4153 | $3.70 | 3.59K |
| Aug 14, 2026 | $3.20 | $3.64 | $3.20 | $3.62 | 27.5K |
| Aug 13, 2026 | $3.08 | $3.49 | $3.05 | $3.20 | 6.84K |
Latest NSRX news
The latest Smart Investors Daily articles mentioning NSRX.
Stock researchResearch & News · SEC Filings
Loading stock research…